Alector soars as Roche licenses Parkinson's therapy for up to $1.27 billion - Reuters
Alector soars as Roche licenses Parkinson's therapy for up to $1.27 billion Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxQOFIzVzd3emp4eHRpVUEtR0NSUlJnQ19ldnVlU0M5U3daYk1WRmktRy1UMTNnUWR4OFNqcktyMUR1cjR3dTJTX0trUFZhZTVjOUN3WERVMU5fcHRkaENiTk1oS3hPdFJWU21VMVQ2LU81VUVYaTVBMURIRUpXbHRyT1A1ZzFFQndNY2dmb2NQYkQtYjFIdmpQM0FxcXdKUXg5bHV5bnhzeHJjby1JNFlGdUlScnRHQQ?oc=5" target="_blank">Alector soars as Roche licenses Parkinson's therapy for up to $1.27 billion</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal - Reuters
Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal Reuters
October 8, 2026 at 02:39 PMGerman robot startup RobCo hits $1 billion valuation, CEO moves to US - Reuters
German robot startup RobCo hits $1 billion valuation, CEO moves to US Reuters
October 5, 2026 at 05:25 PMNvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom - Reuters
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom Reuters
October 8, 2026 at 06:18 PMBecton Dickinson pledges $19 billion US investment in deal with government - Reuters
Becton Dickinson pledges $19 billion US investment in deal with government Reuters
October 6, 2026 at 03:06 PMHalozyme wins court order to block Merck's injected Keytruda in select European markets - Reuters
Halozyme wins court order to block Merck's injected Keytruda in select European markets Reuters
October 7, 2026 at 05:03 PMMcKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal - Reuters
McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal Reuters
October 6, 2026 at 04:30 PM